Antagonism of NK-1R using aprepitant suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes

References

• McGonagle D, Watad A, Savic S. Mechanistic immunological based classification of rheumatoid arthritis. Autoimmun Rev. 2018;17:1115–1123.
   PubMed Web of Science ®Google Scholar
• Zhang A, Lee YC. Mechanisms for joint pain in rheumatoid arthritis (RA): from cytokines to central sensitization. Curr Osteoporos Rep. 2018;16:603–610.
   PubMed Web of Science ®Google Scholar
• Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013;9:24–33.
   PubMed Web of Science ®Google Scholar
• Bustamante MF, Garcia-Carbonell R, Whisenant KD, et al. Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther. 2017;19:110.
   PubMed Web of Science ®Google Scholar
• Phull AR, Nasir B, Haq IU, et al. Oxidative stress, consequences and ROS mediated cellular signaling in rheumatoid arthritis. Chem Biol Interact. 2018;281:121–136.
   PubMed Web of Science ®Google Scholar
• Araki Y, Mimura T. Matrix metalloproteinase gene activation resulting from disordred epigenetic mechanisms in rheumatoid arthritis. IJMS. 2017;18:905.
   Web of Science ®Google Scholar
• Schank JR, Heilig M. Substance P and the neurokinin-1 receptor: the New CRF. Int Rev Neurobiol. 2017;136:151–175.
   PubMed Web of Science ®Google Scholar
• Yip J, Chahl LA. Localization of tachykinin receptors and Fos-like immunoreactivity induced by substance P in guinea-pig brain. Clin Exp Pharmacol Physiol. 2000;27:943–946.
   PubMed Web of Science ®Google Scholar
• Ebner K, Muigg P, Singewald G, et al. Substance P in stress and anxiety: NK-1 receptor antagonism interacts with key brain areas of the stress circuitry. Ann N Y Acad Sci. 2008;1144:61–73.
   PubMed Web of Science ®Google Scholar
• Gautam M, Prasoon P, Kumar R, et al. Role of neurokinin type 1 receptor in nociception at the periphery and the spinal level in the rat. Spinal Cord. 2016;54:172–182.
   PubMed Web of Science ®Google Scholar
• Bošnjak SM, Gralla RJ, Schwartzberg L. Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists. Support Care Cancer. 2017;25:1661–1671.
   PubMed Web of Science ®Google Scholar
• Mou L, Kang Y, Zhou Y, et al. Neurokinin-1 receptor directly mediates glioma cell migration by up-regulation of matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-MMP). J Biol Chem. 2013;288:306–318.
   PubMed Web of Science ®Google Scholar
• Drevet S, Gavazzi G, Grange L, et al. Reactive oxygen species and NADPH oxidase 4 involvement in osteoarthritis. Exp Gerontol. 2018;111:107–117.
   PubMed Web of Science ®Google Scholar
• Hayashi N, Nishimura K, Kumagai S. New biomarkers for rheumatoid arthritis. Rinsho Byori. 2008;56:297–308.
   PubMedGoogle Scholar
• Audo R, Hegglin A, Severac D, et al. Identifcation of genes regulating TRAIL-induced apoptosis in rheumatoid arthritis fbroblasts-like synoviocytes. Genes Immun. 2015;16:462–469.
   PubMed Web of Science ®Google Scholar
• Garcia-Recio S, Gascón P. Biological and pharmacological aspects of the NK1-receptor. Biomed Res Int. 2015;2015:495704.
   PubMed Web of Science ®Google Scholar
• Johnson MB, Young AD, Marriott I. The therapeutic potential of targeting substance P/NK-1R interactions in inflammatory CNS disorders. Front Cell Neurosci. 2017;10:296.
   PubMed Web of Science ®Google Scholar
• Patel L, Lindley C. Aprepitant-a novel NK1-receptor antagonist. Expert Opin Pharmacother. 2003;4:2279–2296.
   PubMed Web of Science ®Google Scholar
• Quartara L, Altamura M. Tachykinin receptors antagonists: from research to clinic. Curr Drug Targets. 2006;7: 975–992.
   PubMed Web of Science ®Google Scholar
• Zhai KF, Duan H, Khan GJ, et al. Salicin from alangium chinense ameliorates rheumatoid arthritis by modulating the Nrf2-HO-1-ROS pathways. J Agric Food Chem. 2018;66:6073–6082.
   PubMed Web of Science ®Google Scholar
• Zhai KF, Duan H, Luo L, et al. Protective effects of paeonol on inflammatory response in IL-1β-induced human fibroblast-like synoviocytes and rheumatoid arthritis progression via modulating NF-κB pathway. Inflammopharmacology. 2017 Aug 10. doi: 10.1007/s10787-017-0385-5.
   Web of Science ®Google Scholar
• Zhai KF, Duan H, Chen Y, et al. Apoptosis effects of imperatorin on synoviocytes in rheumatoid arthritis through mitochondrial/caspase-mediated pathways. Food Funct. 2018;9:2070–2079.
   PubMed Web of Science ®Google Scholar
• Gu X, Gu B, Lv X, et al. 1, 25-dihydroxy-vitamin D3 with tumor necrosis factor-alpha protects against rheumatoid arthritis by promoting p53 acetylation-mediated apoptosis via Sirt1 in synoviocytes. Cell Death Dis. 2016;7:e2423.
   PubMed Web of Science ®Google Scholar
• Lee A, Qiao Y, Grigoriev G, et al. Tumor necrosis factor alpha induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts. Arthritis Rheumatol. 2013;65:928–938.
   PubMed Web of Science ®Google Scholar
• Lim H, Lee SH, Lee HT, et al. Structural biology of the TNFα antagonists used in the treatment of rheumatoid arthritis. Int J Mol Sci. 2018 Mar 7;19. pii: E768.
   Google Scholar
• Martinez AN, Burmeister AR, Ramesh G, et al. Aprepitant limits in vivo neuroinflammatory responses in a rhesus model of Lyme neuroborreliosis. J Neuroinflammation. 2017;14:37.
   PubMed Web of Science ®Google Scholar
• Chenevier-Gobeaux C, Lemarechal H, Bonnefont-Rousselot D, et al. Superoxide production and NADPH oxidase expression in human rheumatoid synovial cells: regulation by interleukin-1beta and tumour necrosis factor-alpha. Inflamm Res. 2006;55:483–490.
   PubMed Web of Science ®Google Scholar